Drug intelligence / Profile preview

SeroVital

Development stage
Unknown
Lead developer
Sanmedica International
Modality
Small Molecules
Administration
Oral
01

Overview

SeroVital is an orally administered dietary supplement developed by Sanmedica International, designed to stimulate the endogenous release of human growth hormone (hGH) from the pituitary gland. It consists of a proprietary blend of amino acids and amino acid derivatives, specifically L-lysine, L-arginine, oxo-proline, N-acetyl-L-cysteine, and L-glutamine, along with the herb Schizonepeta (Japanese catnip). The supplement's primary mechanism of action is the suppression of somatostatin (growth hormone-inhibiting hormone), a natural inhibitor of hGH and thyroid-stimulating hormone (TSH). By inhibiting somatostatin, SeroVital facilitates a significant increase in endogenous hGH levels. Clinical research conducted at the Pennington Biomedical Research Center, including a randomized, double-blind, crossover trial (NCT01540773), demonstrated a 682% increase in mean serum hGH levels 120 minutes after oral administration in healthy volunteers. It is primarily marketed for anti-aging benefits, wellness, and the optimization of growth hormone levels in healthy adults.

Brand names
SeroVitalSeroVital-hgh
Other names
amino acid supplement-Pennington Biomedical Research Centeramino acid-based hGH secretagogue
02

Targets

SST (Somatostatin)

Beyond the preview

Go deeper on SeroVital.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SeroVital.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call